Skip to content
MedsAcross

Medicine

Meropenem 1 g powder for injection

Meropenem · Intravenous
Available on requestPrescription onlyUS FDAGeneric name

Meropenem 1 g powder for injection is a generic prescription medicine for intravenous use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

The dry powder should be stored at controlled room temperature 20º to 25ºC…

Key facts

Active ingredient (INN)
Meropenem
Brand
Sold under the generic name
Strength
1 g
Dosage form
Powder for injection
Route
Intravenous
Packs
10 vials and 1 more
Manufacturers
EugiaIndiaWG Critical CareXellia Pharmaceuticals
Origin register
US FDA, United States
Storage
The dry powder should be stored at controlled room temperature 20º to 25ºC (68º to 77ºF).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
J01DH02 Meropenem
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
27 March 2017
Identifiers
RxCUI 1722934, 1722939DailyMed set ID 6520ae3d-e149-499c-8152-36f6ab861662, bf1d3433-9e3f-40a0-8bff-c8ceaa8bab7c, 74ff19b5-6156-4a27-affb-744b0ce1aeec +1NDC 44567-146, 55150-208, 44567-401 +1Application ANDA210773, ANDA205835, ANDA206141

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
10 vial in 1 carton / 1 injection, powder, for solution in 1 vial55150-208-30EugiaIndia27 March 2017
10 vial in 1 carton / 1 injection, powder, for solution in 1 vial44567-146-10WG Critical Care30 June 2021
10 vial in 1 carton / 1 injection, powder, for solution in 1 vial44567-401-10WG Critical Care9 January 2020
10 vial, glass in 1 carton / 1 injection, powder, for solution in 1 vial, glass70594-076-02Xellia Pharmaceuticals28 June 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 21 June 1996Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Meropenem

Clinical summary

Meropenem is a penem antibacterial indicated for the treatment of complicated skin and skin structure infections (adult patients and pediatric patients 3 months of age and older requiring the full adult dose only), among other approved uses. MedsAcross supplies Meropenem for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Meropenem

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Meropenem 1 g powder for injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.